Report from the Sub-comittee on the environment and health
Report from the Sub-comittee on the environment and health
Report from the Sub-comittee on the environment and health
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
triallate llh -55 I 0.98<br />
prosulfocarb llh -81 I 1<br />
mancozeb llh -162 I 1<br />
pencycur<strong>on</strong> llh -84 I 1<br />
tolclofos-methyl llh -96 I 1<br />
malathi<strong>on</strong> llh -289 I 0.94<br />
dichlorprop-P llh -13 M 0.97<br />
linur<strong>on</strong> lll -11 M 0.85<br />
propic<strong>on</strong>azole lll -11 M 0.49<br />
phenmedipham lll -18 M 0.76<br />
propaquizafop lll -26 M 0.47<br />
triflusulfur<strong>on</strong>-methyl lll -21 M 0.65<br />
chlorfenvinphos lll -26 I 0.88<br />
esfenvalerate lll -19 I 0.44<br />
fluazinam lll -32 I 0.53<br />
propyzamide lll -74 I 0.65<br />
ioxynil lll -167 I 0.7<br />
fuberidazole lll -163 I 0.11<br />
prochloraz lll -44 I 0.46<br />
fenpropidin lll -44 I 0.6<br />
chlorothal<strong>on</strong>il lll -98 I 0.84<br />
propamocarb lll -171 I 0.76<br />
mepiquat-chloride lll -209 I 0.57<br />
bromoxynil lll -199 I 0.64<br />
imazalil lll -60 I 0.07<br />
fenpicl<strong>on</strong>il lll -12 I 0.22<br />
maneb lll -300 I 1<br />
napropamide lll -119 I 0.46<br />
e<str<strong>on</strong>g>the</str<strong>on</strong>g>ph<strong>on</strong> lll -300 I 0.43<br />
furathiocarb lll -300 I 0.33<br />
fenpropimorph lll -300 I 0.57<br />
cypermethrin lll -165 I 0.14<br />
acl<strong>on</strong>ifen lll -190 I 0.79<br />
fluazifop-P-butyl lll -300 I 0.33<br />
desmedipham lll -256 I 0.2<br />
fenoxaprop-P-ethyl lll -300 I 0.17<br />
pendimethalin lll -234 I 0.55<br />
permethrin lll -300 I 0.2<br />
trinexapac-ethyl lll -300 I 0.53<br />
tefluthrin lll -300 I 0.18<br />
glyphosate lll -300 I 0.53<br />
alpha-cypermethrin lll -300 I 0.09<br />
fludiox<strong>on</strong>il lll -82 I 0.09<br />
tau-fluvalinate lll -300 I 0.06<br />
lambda-cyhalothrin lll -300 I 0.06<br />
a = AF index: log(AF): high = greater than or equal to -10; low = less than -10<br />
b = GUS index: high = S; low = M or I<br />
c = Hasse diagram: high = greater than or equal to 0.9; low = less than 0.9<br />
The cut-off values in table 8.2 are critical for <str<strong>on</strong>g>the</str<strong>on</strong>g> analysis <strong>and</strong> are open to<br />
discussi<strong>on</strong>. Since <str<strong>on</strong>g>the</str<strong>on</strong>g> list is regarded as a relative comparis<strong>on</strong> between<br />
substances, <str<strong>on</strong>g>the</str<strong>on</strong>g> cut-off values have been chosen such that each index<br />
identifies 25-30% of <str<strong>on</strong>g>the</str<strong>on</strong>g> pesticides as more leachable than o<str<strong>on</strong>g>the</str<strong>on</strong>g>rs. The<br />
analyses accord well with each o<str<strong>on</strong>g>the</str<strong>on</strong>g>r, although <str<strong>on</strong>g>the</str<strong>on</strong>g> GUS index is more<br />
closely related to <str<strong>on</strong>g>the</str<strong>on</strong>g> AF index than <str<strong>on</strong>g>the</str<strong>on</strong>g> Hasse diagram is to <str<strong>on</strong>g>the</str<strong>on</strong>g> Gus <strong>and</strong><br />
AF indices. That is because <str<strong>on</strong>g>the</str<strong>on</strong>g> dosage is <strong>on</strong>ly included in <str<strong>on</strong>g>the</str<strong>on</strong>g> Hasse<br />
diagram <strong>and</strong> because <str<strong>on</strong>g>the</str<strong>on</strong>g> Hasse diagram does not include <str<strong>on</strong>g>the</str<strong>on</strong>g><br />
degradati<strong>on</strong>, which is included in <str<strong>on</strong>g>the</str<strong>on</strong>g> o<str<strong>on</strong>g>the</str<strong>on</strong>g>r two indices.<br />
The substances <strong>on</strong> this gross list should be subjected to a more detailed<br />
risk assessment in line with that used in <str<strong>on</strong>g>the</str<strong>on</strong>g> authorisati<strong>on</strong> scheme. In<br />
151